Latest Breaking News On - மீருச் உயிர் - Page 1 : comparemela.com
Mirus launches viral vector transfection kits to address two critical areas
biopharma-reporter.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from biopharma-reporter.com Daily Mail and Mail on Sunday newspapers.
Mirus Bio Introduces the VirusGEN® GMP Product Line for Large-scale Therapeutic Adeno-associated Virus and Lentivirus Production
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.
The Transfection Reagents And Equipment Market To Grow At An Astounding Rate – KSU
ksusentinel.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from ksusentinel.com Daily Mail and Mail on Sunday newspapers.
Gamma Biosiences takes majority stake in Mirus Bio Gamma Biosciences has taken a controlling investment in Mirus Bio, an innovator and developer of biomimetic, cell-adaptive lipid-polymer nanocomplexes (LPNCs) for nucleic acid delivery based in Wisconsin in the US.
Originally developed for therapeutic delivery of RNA, Mirus’ LPNCs have been adapted for a wide range of gene delivery applications.
The deal expands Gamma Biosciences reach in gene therapy and next-generation vaccines, while supporting the launch of Mirus Bio s flagship TransIT VirusGen platform for manufacturing of adeno-associated viruses (AAV) and lentivirus-based viral vectors for gene therapy.
The investment will also help to further develop and commercialize TransIT VirusGen for in vivo delivery applications, according to the parties.